本文選題：心力衰竭 + 再住院率　； 參考：《中國中西醫(yī)結(jié)合雜志》2017年10期

【摘要】：正心力衰竭嚴重威脅著人類健康,隨著現(xiàn)代醫(yī)學的發(fā)展,患病率已逐漸下降,但是心力衰竭導致的病死率和住院率基本保持不變,甚至有上升趨勢[1]。因此如何降低心力衰竭患者的病死率和再住院率,提高生活質(zhì)量成為目前治療的難點和重點。我國心力衰竭的臨床治療中,中醫(yī)藥在穩(wěn)定患者病情、改善西藥治療的不良反應、提高臨床療效方面具有一定的優(yōu)勢,并且逐漸被廣泛地應用于臨床,中西醫(yī)結(jié)合治療心力衰竭逐漸得到廣泛認可[2]。在2014年《中國心力衰竭診斷和治
[Abstract]:Positive heart failure is a serious threat to human health, with the development of modern medicine, the prevalence rate has gradually decreased, but the mortality and hospitalization rate caused by heart failure remain basically unchanged, and even have an upward trend [1].Therefore, how to reduce the mortality and rehospitalization rate of patients with heart failure and improve the quality of life has become the difficulty and focus of current treatment.In the clinical treatment of heart failure in our country, Chinese medicine has some advantages in stabilizing the patient's condition, improving the adverse reaction of western medicine treatment and improving the clinical curative effect, and has been widely used in clinical practice.The treatment of heart failure with integrated Chinese and western medicine has been widely accepted [2].Diagnosis and treatment of Heart failure in China in 2014
【作者單位】： 廣州中醫(yī)藥大學第二附屬醫(yī)院廣東省中醫(yī)院心血管科;
【分類號】：R259
，

本文編號：1744352